Target acquired: Selective autophagy in cardiometabolic disease

Science Signaling

Volumn 10, Issue 468, 2017, Pages

  Evans, Trent D ^a   Sergin, Ismail ^a   Zhang, Xiangyu ^a   Razani, Babak ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; INFLAMMASOME; NBR1 PROTEIN; RECEPTOR; SEQUESTOSOME 1; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; AUTOPHAGOSOME; CARDIOVASCULAR DISEASE; CELL METABOLISM; CYTOLOGY; DIABETES MELLITUS; FATTY LIVER; HUMAN; INFLAMMATION; LIPOPHAGOCYTOSIS; METABOLIC DISORDER; MITOPHAGY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PEXOPHAGY; PRIORITY JOURNAL; REVIEW; SELECTIVE AUTOPHAGY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; AUTOPHAGY; BIOLOGICAL MODEL; METABOLISM;

ATHEROSCLEROSIS; AUTOPHAGOSOMES; AUTOPHAGY; DIABETES MELLITUS; FATTY LIVER; HUMANS; MODELS, BIOLOGICAL; OBESITY; SEQUESTOSOME-1 PROTEIN; SIGNAL TRANSDUCTION;

EID: 85014629469     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aag2298     Document Type: Review

References (252)

1. G. A. Roth, M. D. Huffman, A. E. Moran, V. Feigin, G. A. Mensah, M. Naghavi, C. J. L. Murray, Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 132, 1667-1678 (2015).
2. C. Patterson, C. Ike, P. W. Willis 4th, G. A. Stouffer, M. S. Willis, The bitter end: The ubiquitin-proteasome system and cardiac dysfunction. Circulation 115, 1456-1463 (2007).
3. D. Versari, J. Herrmann, M. Gössl, D. Mannheim, K. Sattler, F. B. Meyer, L. O. Lerman, A. Lerman, Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 2132-2139 (2006).
4. K. R. Parzych, D. J. Klionsky, An overview of autophagy: Morphology, mechanism, and regulation. Antioxid. Redox Signal. 20, 460-473 (2014).
5. N. Mizushima, M. Komatsu, Autophagy: Renovation of cells and tissues. Cell 147, 728-741 (2011).
6. C. Kraft, M. Peter, K. Hofmann, Selective autophagy: Ubiquitin-mediated recognition and beyond. Nat. Cell Biol. 12, 836-841 (2010).
7. D. J. Klionsky, E. H. Baehrecke, J. H. Brumell, C. T. Chu, P. Codogno, A. M. Cuervo, J. Debnath, V. Deretic, Z. Elazar, E.-L. Eskelinen, S. Finkbeiner, J. Fueyo-Margareto, D. A. Gewirtz, M. Jäättelä, G. Kroemer, B. Levine, T. J. Melia, N. Mizushima, D. C. Rubinsztein, A. Simonsen, A. Thorburn, M. Thumm, S. A. Tooze, A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy 7, 1273-1294 (2011).
8. P. Xu, D. M. Duong, N. T. Seyfried, D. Cheng, Y. Xie, J. Robert, J. Rush, M. Hochstrasser, D. Finley, J. Peng, Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137, 133-145 (2009).
9. M. S. Willis, C. Patterson, Proteotoxicity and cardiac dysfunction-Alzheimer's disease of the heart? N. Engl. J. Med. 368, 455-464 (2013).
10. R. R. Kopito, Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530 (2000).
11. E. J. Bennett, N. F. Bence, R. Jayakumar, R. R. Kopito, Global impairment of the ubiquitinproteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell 17, 351-365 (2005).
12. T. Lamark, T. Johansen, Aggrephagy: Selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 736905 (2012).
13. S. Murata, Y. Minami, M. Minami, T. Chiba, K. Tanaka, CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2, 1133-1138 (2001).
14. J. A. Olzmann, L.-S. Chin, Parkin-mediated K63-linked polyubiquitination: A signal for targeting misfolded proteins to the aggresome-Autophagy pathway. Autophagy 4, 85-87 (2008).
15. M. Gamerdinger, S. Carra, C. Behl, Emerging roles of molecular chaperones and cochaperones in selective autophagy: Focus on BAG proteins. J. Mol. Med. 89, 1175-1182 (2011).
16. M. Gamerdinger, A. M. Kaya, U. Wolfrum, A. M. Clement, C. Behl, BAG3 mediates chaperone-based aggresome-Targeting and selective autophagy of misfolded proteins. EMBO Rep. 12, 149-156 (2011).
17. S. Pankiv, T. H. Clausen, T. Lamark, A. Brech, J.-A. Bruun, H. Outzen, A. Øvervatn, G. Bjørkøy, T. Johansen, p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131-24145 (2007).
18. M. Komatsu, S. Waguri, M. Koike, Y.-s. Sou, T. Ueno, T. Hara, N. Mizushima, J.-i. Iwata, J. Ezaki, S. Murata, J. Hamazaki, Y. Nishito, S.-i. Iemura, T. Natsume, T. Yanagawa, J. Uwayama, E. Warabi, H. Yoshida, T. Ishii, A. Kobayashi, M. Yamamoto, Z. Yue, Y. Uchiyama, E. Kominami, K. Tanaka, Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131, 1149-1163 (2007).
19. I. Sergin, S. Bhattacharya, R. Emanuel, E. Esen, C. J. Stokes, T. D. Evans, B. Arif, J. A. Curci, B. Razani, Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis. Sci. Signal. 9, ra2 (2016).
20. C. Stumptner, A. Fuchsbichler, K. Zatloukal, H. Denk, In vitro production of Mallory bodies and intracellular hyaline bodies: The central role of sequestosome 1/p62. Hepatology 46, 851-860 (2007).
21. M. Filimonenko, P. Isakson, K. D. Finley, M. Anderson, H. Jeong, T. J. Melia, B. J. Bartlett, K. M. Myers, H. C. G. Birkeland, T. Lamark, D. Krainc, A. Brech, H. Stenmark, A. Simonsen, The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol. Cell 38, 265-279 (2010).
22. Y. Fukuo, S. Yamashina, H. Sonoue, A. Arakawa, E. Nakadera, T. Aoyama, A. Uchiyama, K. Kon, K. Ikejima, S. Watanabe, Abnormality of autophagic function and cathepsin expression in the liver from patients with non-Alcoholic fatty liver disease. Hepatol. Res. 44, 1026-1036 (2014).
23. K. Zatloukal, C. Stumptner, A. Fuchsbichler, H. Heid, M. Schnoelzer, L. Kenner, R. Kleinert, M. Prinz, A. Aguzzi, H. Denk, p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160, 255-263 (2002).
24. K. Zatloukal, S. W. French, C. Stumptner, P. Strnad, M. Harada, D. M. Toivola, M. Cadrin, M. B. Omary, From Mallory to Mallory-Denk bodies: What, how and why? Exp. Cell Res. 313, 2033-2049 (2007).
25. Y. Peng, B. A. French, B. Tillman, T. R. Morgan, S. W. French, The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp. Mol. Pathol. 97, 305-313 (2014).
26. Y. Inami, S. Waguri, A. Sakamoto, T. Kouno, K. Nakada, O. Hino, S. Watanabe, J. Ando, M. Iwadate, M. Yamamoto, M.-S. Lee, K. Tanaka, M. Komatsu, Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 193, 275-284 (2011).
27. R. Mathew, C. M. Karp, B. Beaudoin, N. Vuong, G. Chen, H.-Y. Chen, K. Bray, A. Reddy, G. Bhanot, C. Gelinas, R. S. DiPaola, V. Karantza-Wadsworth, E. White, Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062-1075 (2009).
28. H.-M. Ni, B. L. Woolbright, J. Williams, B. Copple, W. Cui, J. P. Luyendyk, H. Jaeschke, W.-X. Ding, Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy. J. Hepatol. 61, 617-625 (2014).
29. M. Komatsu, H. Kurokawa, S. Waguri, K. Taguchi, A. Kobayashi, Y. Ichimura, Y.-S. Sou, I. Ueno, A. Sakamoto, K. I. Tong, M. Kim, Y. Nishito, S.-i. Iemura, T. Natsume, T. Ueno, E. Kominami, H. Motohashi, K. Tanaka, M. Yamamoto, The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12, 213-223 (2010).
30. A. Takamura, M. Komatsu, T. Hara, A. Sakamoto, C. Kishi, S. Waguri, Y. Eishi, O. Hino, K. Tanakaand, N. Mizushima, Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 25, 795-800 (2011).
31. J. Moscat, M. T. Diaz-Meco, p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137, 1001-1004 (2009).
32. A. Umemura, F. He, K. Taniguchi, H. Nakagawa, S. Yamachika, J. Font-Burgada, Z. Zhong, S. Subramaniam, S. Raghunandan, A. Duran, J. F. Linares, M. Reina-Campos, S. Umemura, M. A. Valasek, E. Seki, K. Yamaguchi, K. Koike, Y. Itoh, M. T. Diaz-Meco, J. Moscat, M. Karin, p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 29, 935-948 (2016).
33. A. Duran, E. D. Hernandez, M. Reina-Campos, E. A. Castilla, S. Subramaniam, S. Raghunandan, L. R. Roberts, T. Kisseleva, M. Karin, M. T. Diaz-Meco, J. Moscat, p62/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer. Cancer Cell 30, 595-609 (2016).
34. T. D. Müller, S. J. Lee, M. Jastroch, D. Kabra, K. Stemmer, M. Aichler, B. Abplanalp, G. Ananthakrishnan, N. Bhardwaj, S. Collins, S. Divanovic, M. Endele, B. Finan, Y. Gao, K. M. Habegger, J. Hembree, K. M. Heppner, S. Hofmann, J. Holland, D. Küchler, M. Kutschke, R. Krishna, M. Lehti, R. Oelkrug, N. Ottaway, D. Perez-Tilve, C. Raver, A. K. Walch, S. C. Schriever, J. Speakman, Y.-H. Tseng, M. Diaz-Meco, P. T. Pfluger, J. Moscat, M. H. Tschöp, P62 links b-Adrenergic input to mitochondrial function and thermogenesis. J. Clin. Invest. 123, 469-478 (2013).
35. P. Lahiri, V. Schmidt, C. Smole, I. Kufferath, H. Denk, P. Strnad, T. Rülicke, L. F. Fröhlich, K. Zatloukal, p62/Sequestosome-1 is indispensable for maturation and stabilization of Mallory-Denk bodies. PLOS ONE 11, e0161083 (2016).
36. J. Janson, R. H. Ashley, D. Harrison, S. McIntyre, P. C. Butler, The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491-498 (1999).
37. S. Despa, S. Sharma, T. R. Harris, H. Dong, N. Li, N. Chiamvimonvat, H. Taegtmeyer, K. B. Margulies, B. D. Hammock, F. Despa, Cardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat model. J. Am. Heart Assoc. 3, e001015 (2014).
38. S. Despa, K. B. Margulies, L. Chen, A. A. Knowlton, P. J. Havel, H. Taegtmeyer, D. M. Bers, F. Despa, Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: A study in humans and rats. Circ. Res. 110, 598-608 (2012).
39. J. F. Rivera, T. Gurlo, M. Daval, C. J. Huang, A. V. Matveyenko, P. C. Butler, S. Costes, Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic b-cells: Protective role of p62-positive cytoplasmic inclusions. Cell Death Differ. 18, 415-426 (2011).
40. J. F. Rivera, S. Costes, T. Gurlo, C. G. Glabe, P. C. Butler, Autophagy defends pancreatic b cells from human islet amyloid polypeptide-induced toxicity. J. Clin. Invest. 124, 3489-3500 (2014).
41. J. Kim, H. Cheon, Y. T. Jeong, W. Quan, K. H. Kim, J. M. Cho, Y.-M. Lim, S. H. Oh, S.-M. Jin, J. H. Kim, M.-K. Lee, S. Kim, M. Komatsu, S.-W. Kang, M.-S. Lee, Amyloidogenic peptide oligomer accumulation in autophagy-deficient b cells induces diabetes. J. Clin. Invest. 124, 3311-3324 (2014).
42. N. Shigihara, A. Fukunaka, A. Hara, K. Komiya, A. Honda, T. Uchida, H. Abe, Y. Toyofuku, M. Tamaki, T. Ogihara, T. Miyatsuka, H. J. Hiddinga, S. Sakagashira, M. Koike, Y. Uchiyama, T. Yoshimori, N. L. Eberhardt, Y. Fujitani, H. Watada, Human IAPP-induced pancreatic b cell toxicity and its regulation by autophagy. J. Clin. Invest. 124, 3634-3644 (2014).
43. R. Emanuel, I. Sergin, S. Bhattacharya, J. N. Turner, S. Epelman, C. Settembre, A. Diwan, A. Ballabio, B. Razani, Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae. Arterioscler. Thromb. Vasc. Biol. 34, 1942-1952 (2014).
44. J. Herrmann, W. D. Edwards, D. R. Holmes, K. L. Shogren, L. O. Lerman, A. Ciechanover, A. Lerman, Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes. J. Am. Coll. Cardiol. 40 1919-1927 (2002).
45. W. Jessup, E. L. Mander, R. T. Dean, The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim. Biophys. Acta 1126, 167-177 (1992).
46. F. Ursini, K. J. A. Davies, M. Maiorino, T. Parasassi, A. Sevanian, Atherosclerosis: Another protein misfolding disease? Trends Mol. Med. 8, 370-374 (2002).
47. H. F. Hoff, N. Zyromski, D. Armstrong, J. O'Neil, Aggregation as well as chemical modification of LDL during oxidation is responsible for poor processing in macrophages. J. Lipid Res. 34, 1919-1929 (1993).
48. S. L. Masters, A. Dunne, S. L. Subramanian, R. L. Hull, G. M. Tannahill, F. A. Sharp, C. Becker, L. Franchi, E. Yoshihara, Z. Chen, N. Mullooly, L. A. Mielke, J. Harris, R. C. Coll, K. H. G. Mills, K. H. Mok, P. Newsholme, G. Nuñez, J. Yodoi, S. E. Kahn, E. C. Lavelle, L. A. J. O'Neill, Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1b in type 2 diabetes. Nat. Immunol. 11, 897-904 (2010).
49. M. E. Kotas, R. Medzhitov, Homeostasis, inflammation, and disease susceptibility. Cell 160, 816-827 (2015).
50. B. Vandanmagsar, Y.-H. Youm, A. Ravussin, J. E. Galgani, K. Stadler, R. L. Mynatt, E. Ravussin, J. M. Stephens, V. D. Dixit, The NLRP3 inflammasome instigates obesityinduced inflammation and insulin resistance. Nat. Med. 17, 179-188 (2011).
51. P. Duewell, H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, F. G. Bauernfeind, G. S. Abela, L. Franchi, G. Nuñez, M. Schnurr, T. Espevik, E. Lien, K. A. Fitzgerald, K. L. Rock, K. J. Moore, S. D. Wright, V. Hornung, E. Latz, NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361 (2010).
52. D. De Nardo, E. Latz, NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol. 32, 373-379 (2011).
53. R. Stienstra, J. A. van Diepen, C. J. Tack, M. H. Zaki, F. L. van de Veerdonk, D. Perera, G. A. Neale, G. J. Hooiveld, A. Hijmans, I. Vroegrijk, S. van den Berg, J. Romijn, P. C. N. Rensen, L. A. B. Joosten, M. G. Netea, T.-D. Kanneganti, Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 108, 15324-15329 (2011).
54. S. L. Masters, E. Latz, L. A. J. O'Neill, The inflammasome in atherosclerosis and type 2 diabetes. Sci. Transl. Med. 3, 81ps17 (2011).
55. H.-M. Lee, J.-J. Kim, H. J. Kim, M. Shong, B. J. Ku, E.-K. Jo, Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62, 194-204 (2013).
56. C.-S. Shi, K. Shenderov, N.-N. Huang, J. Kabat, M. Abu-Asab, K. A. Fitzgerald, A. Sher, J. H. Kehrl, Activation of autophagy by inflammatory signals limits IL-1b production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 13, 255-263 (2012).
57. Z. Zhong, A. Umemura, E. Sanchez-Lopez, S. Liang, S. Shalapour, J. Wong, F. He, D. Boassa, G. Perkins, S. R. Ali, M. D. McGeough, M. H. Ellisman, E. Seki, A. B. Gustafsson, H. M. Hoffman, M. T. Diaz-Meco, J. Moscat, M. Karin, NF-kB restricts inflammasome activation via elimination of damaged mitochondria. Cell 164, 896-910 (2016).
58. T. Kimura, A. Jain, S. W. Choi, M. A. Mandell, K. Schroder, T. Johansen, V. Deretic, TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J. Cell Biol. 210, 973-989 (2015).
59. T. Kimura, A. Jain, S. W. Choi, M. A. Mandell, T. Johansen, V. Deretic, TRIM-directed selective autophagy regulates immune activation. Autophagy 10.1080/15548627.2016.1154254 (2016).
60. T. Kimura, M. Mandell, V. Deretic, Precision autophagy directed by receptor regulatorsemerging examples within the TRIM family. J. Cell Sci. 129, 881-891 (2016).
61. A. Omenetti, S. Carta, L. Delfino, A. Martini, M. Gattorno, A. Rubartelli, Increased NLRP3- dependent interleukin 1b secretion in patients with familial Mediterranean fever: Correlation with MEFV genotype. Ann. Rheum. Dis. 73, 462-469 (2014).
62. A. Acay, M. S. Ulu, A. Ahsen, G. Ozkececi, K. Demir, U. Ozuguz, S. Yuksel, G. Acarturk, Atherogenic index as a predictor of atherosclerosis in subjects with familial Mediterranean fever. Medicina 50, 329-333 (2014).
63. A. Akdogan, M. Calguneri, B. Yavuz, E. B. Arslan, U. Kalyoncu, L. Sahiner, O. Karadag, I. Ertenli, S. Kiraz, K. Aytemir, D. Akata, L. Tokgozoglu, A. Oto, Are familial Mediterranean Fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J. Am. Coll. Cardiol. 48, 2351-2353 (2006).
64. E. Aflaki, N. Moaven, D. K. Borger, G. Lopez, W. Westbroek, J. J. Chae, J. Marugan, S. Patnaik, E. Maniwang, A. N. Gonzalez, E. Sidransky, Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages. Aging Cell 15, 77-88 (2016).
65. H.-W. Chiu, C.-H. Chen, J.-N. Chang, C.-H. Chen, Y.-H. Hsu, Far-infrared promotes burn wound healing by suppressing NLRP3 inflammasome caused by enhanced autophagy. J. Mol. Med. 94, 809-819 (2016).
66. Y. Yan, W. Jiang, L. Liu, X. Wang, C. Ding, Z. Tian, R. Zhou, Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160, 62-73 (2015).
67. B. Razani, C. Feng, T. Coleman, R. Emanuel, H. Wen, S. Hwang, J. P. Ting, H. W. Virgin, M. B. Kastan, C. F. Semenkovich, Autophagy links inflammasomes to atherosclerotic progression. Cell Metab. 15, 534-544 (2012).
68. Y.-M. Lim, H. Lim, K. Y. Hur, W. Quan, H.-Y. Lee, H. Cheon, D. Ryu, S.-H. Koo, H. L. Kim, J. Kim, M. Komatsu, M.-S. Lee, Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes. Nat. Commun. 5, 4934 (2014).
69. J. Lodder, T. Denaës, M.-N. Chobert, J. H. Wan, J. El-Benna, J.-M. Pawlotsky, S. Lotersztajn, F. Teixeira-Clerc, Macrophage autophagy protects against liver fibrosis in mice. Autophagy 11, 1280-1292 (2015).
70. K. Nakahira, J. A. Haspel, V. A. K. Rathinam, S.-J. Lee, T. Dolinay, H. C. Lam, J. A. Englert, M. Rabinovitch, M. Cernadas, H. P. Kim, K. A. Fitzgerald, S. W. Ryter, A. M. K. Choi, Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222-230 (2011).
71. R. Zhou, A. S. Yazdi, P. Menu, J. Tschopp, A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225 (2011).
72. J. Yu, H. Nagasu, T. Murakami, H. Hoang, L. Broderick, H. M. Hoffman, T. Horng, Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc. Natl. Acad. Sci. U.S.A. 111, 15514-15519 (2014).
73. J. Harris, M. Hartman, C. Roche, S. G. Zeng, A. O'Shea, F. A. Sharp, E. M. Lambe, E. M. Creagh, D. T. Golenbock, J. Tschopp, H. Kornfeld, K. A. Fitzgeraldand, E. C. Lavelle, Autophagy controls IL-1b secretion by targeting pro-IL-1b for degradation. J. Biol. Chem. 286, 9587-9597 (2011).
74. A. Rubartelli, F. Cozzolino, M. Talio, R. Sitia, A novel secretory pathway for interleukin-1b, a protein lacking a signal sequence. EMBO J. 9, 1503-1510 (1990).
75. N. Dupont, S. Jiang, M. Pilli, W. Ornatowski, D. Bhattacharya, V. Deretic, Autophagybased unconventional secretory pathway for extracellular delivery of IL-1b. EMBO J. 30, 4701-4711 (2011).
76. M. Zhang, S. J. Kenny, L. Ge, K. Xu, R. Schekman, Translocation of interleukin-1b into a vesicle intermediate in autophagy-mediated secretion. eLife 4, e11205 (2015).
77. G. Lopez-Castejon, D. Brough, Understanding the mechanism of IL-1b secretion. Cytokine Growth Factor Rev. 22, 189-195 (2011).
78. I. J. Lodhi, C. F. Semenkovich, Peroxisomes: A nexus for lipid metabolism and cellular signaling. Cell Metab. 19, 380-392 (2014).
79. S. Ferdinandusse, S. Denis, P. L. Faust, R. J. A. Wanders, Bile acids: The role of peroxisomes. J. Lipid Res. 50, 2139-2147 (2009).
80. I. J. Lodhi, L. Yin, A. P. L. Jensen-Urstad, K. Funai, T. Coleman, J. H. Baird, M. K. El Ramahi, B. Razani, H. Song, F. Fu-Hsu, J. Turk, C. F. Semenkovich, Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARg activation to decrease diet-induced obesity. Cell Metab. 16, 189-201 (2012).
81. G. Jedlitschky, M. Hubert, A. Völkl, M. Müller, I. Leier, J. Müller, W.-D. Lehmann, H. D. Fahimi, D. Keppler, Peroxisomal degradation of leukotrienes by b-oxidation from the w-end. J. Biol. Chem. 266, 24763-24772 (1991).
82. B. Wang, P. P. Van Veldhoven, C. Brees, N. Rubio, M. Nordgren, O. Apanasets, M. Kunze, M. Baes, P. Agostinis, M. Fransen, Mitochondria are targets for peroxisomederived oxidative stress in cultured mammalian cells. Free Radic. Biol. Med. 65, 882-894 (2013).
83. M. Schrader, H. D. Fahimi, Peroxisomes and oxidative stress. Biochim. Biophys. Acta 1763, 1755-1766 (2006).
84. M. Elsner, W. Gehrmann, S. Lenzen, Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes 60, 200-208 (2011).
85. V. I. Titorenko, S. R. Terlecky, Peroxisome metabolism and cellular aging. Traffic 12, 252-259 (2011).s
86. M. Komatsu, S. Waguri, T. Ueno, J. Iwata, S. Murata, I. Tanida, J. Ezaki, N. Mizushima, Y. Ohsumi, Y. Uchiyama, E. Kominami, K. Tanaka, T. Chiba, Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169, 425-434 (2005).
87. J.-i. Iwata, J. Ezaki, M. Komatsu, S. Yokota, T. Ueno, I. Tanida, T. Chiba, K. Tanaka, E. Kominami, Excess peroxisomes are degraded by autophagic machinery in mammals. J. Biol. Chem. 281, 4035-4041 (2006).
88. S. Subramani, A mammalian pexophagy target. Nat. Cell Biol. 17, 1371-1373 (2015).
89. J. Zhang, D. N. Tripathi, J. Jing, A. Alexander, J. Kim, R. T. Powell, R. Dere, J. Tait-Mulder, J.-H. Lee, T. T. Paull, R. K. Pandita, V. K. Charaka, T. K. Pandita, M. B. Kastan, C. L. Walker, ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat. Cell Biol. 17, 1259-1269 (2015).
90. J. Zhang, J. Kim, A. Alexander, S. Cai, D. N. Tripathi, R. Dere, A. R. Tee, J. Tait-Mulder, A. Di Nardo, J. M. Han, E. Kwiatkowski, E. A. Dunlop, K. M. Dodd, R. D. Folkerth, P. L. Faust, M. B. Kastan, M. Sahin, C. L. Walker, A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat. Cell Biol. 15, 1186-1196 (2013).
91. M. Nordgren, T. Francisco, C. Lismont, L. Hennebel, C. Brees, B. Wang, P. P. Van Veldhoven, J. E. Azevedo, M. Fransen, Export-deficient monoubiquitinated PEX5 triggers peroxisome removal in SV40 large T antigen-Transformed mouse embryonic fibroblasts. Autophagy 11, 1326-1340 (2015).
92. J. I. Koepke, K.-A. Nakrieko, C. S. Wood, K. K. Boucher, L. J. Terlecky, P. A. Walton, S. R. Terlecky, Restoration of peroxisomal catalase import in a model of human cellular aging. Traffic 8, 1590-1600 (2007).
93. V. Narayan, T. Ly, E. Pourkarimi, A. B. Murillo, A. Gartner, A. I. Lamond, C. Kenyon, Deep proteome analysis identifies age-related processes in C. elegans. Cell Syst. 3, 144-159 (2016).
94. A. I. Brown, P. K. Kim, A. D. Rutenberg, PEX5 and ubiquitin dynamics on mammalian peroxisome membranes. PLOS Comput. Biol. 10, e1003426 (2014).
95. C. P. Grou, T. Francisco, T. A. Rodrigues, M. O. Freitas, M. P. Pinto, A. F. Carvalho, P. Domingues, S. A. Wood, J. E. Rodríguez-Borges, C. Sá-Miranda, M. Fransen, J. E. Azevedo, Identification of ubiquitin-specific protease 9X (USP9X) as a deubiquitinase acting on ubiquitin-peroxin 5 (PEX5) thioester conjugate. J. Biol. Chem. 287, 12815-12827 (2012).
96. G. Sargent, T. van Zutphen, T. Shatseva, L. Zhang, V. Di Giovanni, R. Bandsma, P. K. Kim, PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation. J. Cell Biol. 214, 677-690 (2016).
97. E. Deosaran, K. B. Larsen, R. Hua, G. Sargent, Y. Wang, S. Kim, T. Lamark, M. Jauregui, K. Law, J. Lippincott-Schwartz, A. Brech, T. Johansen, P. K. Kim, NBR1 acts as an autophagy receptor for peroxisomes. J. Cell Sci. 126, 939-952 (2013).
98. K. M. Walter, M. J. Schönenberger, M. Trötzmüller, M. Horn, H.-P. Elsässer, A. B. Moser, M. S. Lucas, T. Schwarz, P. A. Gerber, P. L. Faust, H. Moch, H. C. Köfeler, W. Krek, W. J. Kovacs, Hif-2a promotes degradation of mammalian peroxisomes by selective autophagy. Cell Metab. 20, 882-897 (2014).
99. X. Li, S. J. Gould, PEX11 promotes peroxisome division independently of peroxisome metabolism. J. Cell Biol. 156, 643-651 (2002).
100. K. Mao, X. Liu, Y. Feng, D. J. Klionsky, The progression of peroxisomal degradation through autophagy requires peroxisomal division. Autophagy 10, 652-661 (2014).
101. I. Issemann, S. Green, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650 (1990).
102. U. Edvardsson, M. Bergström, M. Alexandersson, K. Bamberg, B. Ljung, B. Dahllöf, Rosiglitazone (BRL49653), a PPARg-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. J. Lipid Res. 40, 1177-1184 (1999).
103. A. Gatica, M. C. Aguilera, D. Contador, G. Loyola, C. O. Pinto, L. Amigo, J. E. Tichauer, S. Zanlungo, M. Bronfman, P450 CYP2C epoxygenase and CYP4A w-hydroxylase mediate ciprofibrate-induced PPARa-dependent peroxisomal proliferation. J. Lipid Res. 48, 924-934 (2007).
104. A. Bartelt, J. Heeren, Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 10, 24-36 (2014).
105. A. Bagattin, L. Hugendubler, E. Mueller, Transcriptional coactivator PGC-1a promotes peroxisomal remodeling and biogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 20376-20381 (2010).
106. Y. Zhang, S. Goldman, R. Baerga, Y. Zhao, M. Komatsu, S. Jin, Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc. Natl. Acad. Sci. U.S.A. 106, 19860-19865 (2009).
107. I. Hwang, J. Lee, J. Y. Huh, J. Park, H. B. Lee, Y.-S. Ho, H. Ha, Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61, 728-738 (2012).
108. R. Dirkx, I. Vanhorebeek, K. Martens, A. Schad, M. Grabenbauer, D. Fahimi, P. Declercq, P. P. Van Veldhoven, M. Baes, Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities. Hepatology 41, 868-878 (2005).
109. M. H. Keane, H. Overmars, T. M. Wikander, S. Ferdinandusse, M. Duran, R. J. A. Wanders, P. L. Faust, Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice. Hepatology 45, 982-997 (2007).
110. H. Ishii, N. Fukumori, S. Horie, T. Suga, Effects of fat content in the diet on hepatic peroxisomes of the rat. Biochim. Biophys. Acta 617, 1-11 (1980).
111. Y. Wang, G. Z. Wang, P. S. Rabinovitch, I. Tabas, Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-kB-mediated inflammation in macrophages. Circ. Res. 114, 421-433 (2014).
112. T. Ide, H. Tsutsui, S. Kinugawa, H. Utsumi, D. Kang, N. Hattori, K. Uchida, K.-i. Arimura, K. Egashira, A. Takeshita, Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 85, 357-363 (1999).
113. X. Shen, S. Zheng, N. S. Metreveli, P. N. Epstein, Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 55, 798-805 (2006).
114. R. A. Gioscia-Ryan, T. J. LaRocca, A. L. Sindler, M. C. Zigler, M. P. Murphy, D. R. Seals, Mitochondria-Targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice. J. Physiol. 592, 2549-2561 (2014).
115. C. Bonnard, A. Durand, S. Peyrol, E. Chanseaume, M. A. Chauvin, B. Morio, H. Vidal, J. Rieusset, Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin resistant mice. J. Clin. Invest. 118, 789-800 (2008).
116. T. Oka, S. Hikoso, O. Yamaguchi, M. Taneike, T. Takeda, T. Tamai, J. Oyabu, T. Murakawa, H. Nakayama, K. Nishida, S. Akira, A. Yamamoto, I. Komuro, K. Otsu, Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485, 251-255 (2012).
117. K. Shimada, T. R. Crother, J. Karlin, J. Dagvadorj, N. Chiba, S. Chen, V. K. Ramanujan, A. J. Wolf, L. Vergnes, D. M. Ojcius, A. Rentsendorj, M. Vargas, C. Guerrero, Y. Wang, K. A. Fitzgerald, D. M. Underhill, T. Town, M. Arditi, Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401-414 (2012).
118. T. R. Koves, J. R. Ussher, R. C. Noland, D. Slentz, M. Mosedale, O. Ilkayeva, J. Bain, R. Stevens, J. R. B. Dyck, C. B. Newgard, G. D. Lopaschuk, D. M. Muoio, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45-56 (2008).
119. G. Twig, A. Elorza, A. J. A. Molina, H. Mohamed, J. D. Wikstrom, G. Walzer, L. Stiles, S. E. Haigh, S. Katz, G. Las, J. Alroy, M. Wu, B. F. Py, J. Yuan, J. T. Deeney, B. E. Corkey, O. S. Shirihai, Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27, 433-446 (2008).
120. M. Liesa, O. S. Shirihai, Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17, 491-506 (2013).
121. S. M. Jin, M. Lazarou, C. Wang, L. A. Kane, D. P. Narendra, R. J. Youle, Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933-942 (2010).
122. D. P. Narendra, S. M. Jin, A. Tanaka, D.-F. Suen, C. A. Gautier, J. Shen, M. R. Cookson, R. J. Youle, PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLOS Biol. 8, e1000298 (2010).
123. C. N. Cunningham, J. M. Baughman, L. Phu, J. S. Tea, C. Yu, M. Coons, D. S. Kirkpatrick, B. Bingol, J. E. Corn, USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria. Nat. Cell Biol. 17, 160-169 (2015).
124. B. Bingol, J. S. Tea, L. Phu, M. Reichelt, C. E. Bakalarski, Q. Song, O. Foreman, D. S. Kirkpatrick, M. Sheng, The mitochondrial deubiquitinase USP30 opposes parkinmediated mitophagy. Nature 510, 370-375 (2014).
125. M. Lazarou, D. A. Sliter, L. A. Kane, S. A. Sarraf, C. Wang, J. L. Burman, D. P. Sideris, A. I. Fogel, R. J. Youle, The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309-314 (2015).
126. J.-M. Heo, A. Ordureau, J. A. Paulo, J. Rinehart, J. W. Harper, The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60, 7-20 (2015).
127. D. Narendra, L. A. Kane, D. N. Hauser, I. M. Fearnley, R. J. Youle, p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6, 1090-1106 (2010).
128. C. Huang, A. M. Andres, E. P. Ratliff, G. Hernandez, P. Lee, R. A. Gottlieb, Preconditioning involves selective mitophagy mediated by parkin and p62/SQSTM1. PLOS ONE 6, e20975 (2011).
129. R. A. Hanna, M. N. Quinsay, A. M. Orogo, K. Giang, S. Rikka, Å. B. Gustafsson, Microtubuleassociated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem. 287, 19094-19104 (2012).
130. J. Zhang, P. A. Ney, Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16, 939-946 (2009).
131. A. Hamacher-Brady, N. R. Brady, S. E. Logue, M. R. Sayen, M. Jinno, L. A. Kirshenbaum, R. A. Gottlieb, Å. B. Gustafsson, Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 14, 146-157 (2007).
132. R. Sumpter Jr., S. Sirasanagandla, Á. F. Fernández, Y. Wei, X. Dong, L. Franco, Z. Zou, C. Marchal, M. Y. Lee, D. W. Clapp, H. Hanenberg, B. Levine, Fanconi anemia proteins function in mitophagy and immunity. Cell 165, 867-881 (2016).
133. L. Liu, D. Feng, G. Chen, M. Chen, Q. Zheng, P. Song, Q. Ma, C. Zhu, R. Wang, W. Qi, L. Huang, P. Xue, B. Li, X. Wang, H. Jin, J. Wang, F. Yang, P. Liu, Y. Zhu, S. Sui, Q. Chen, Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14, 177-185 (2012).
134. F. Strappazzon, F. Nazio, M. Corrado, V. Cianfanelli, A. Romagnoli, G. M. Fimia, S. Campello, R. Nardacci, M. Piacentini, M. Campanella, F. Cecconi, AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ. 22, 419-432 (2015).
135. E. Masiero, L. Agatea, C. Mammucari, B. Blaauw, E. Loro, M. Komatsu, D. Metzger, C. Reggiani, S. Schiaffino, M. Sandri, Autophagy is required to maintain muscle mass. Cell Metab. 10, 507-515 (2009).
136. K. H. Kim, Y. T. Jeong, H. Oh, S. H. Kim, J. M. Cho, Y.-N. Kim, S. S. Kim, D. H. Kim, K. Y. Hur, H. K. Kim, T. Ko, J. Han, H. L. Kim, J. Kim, S. H. Back, M. Komatsu, H. Chen, D. C. Chan, M. Konishi, N. Itoh, C. S. Choi, M.-S. Lee, Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat. Med. 19, 83-92 (2013).
137. R. E. Gimeno, D. E. Moller, FGF21-based pharmacotherapy-potential utility for metabolic disorders. Trends Endocrinol. Metab. 25, 303-311 (2014).
138. V. Ribas, B. G. Drew, Z. Zhou, J. Phun, N. Y. Kalajian, T. Soleymani, P. Daraei, K. Widjaja, J. Wanagat, T. Q. De Aguiar Vallim, A. H. Fluitt, S. Bensinger, T. Le, C. Radu, J. P. Whitelegge, S. W. Beaven, P. Tontonoz, A. J. Lusis, B. W. Parks, L. Vergnes, K. Reue, H. Singh, J. C. Bopassa, L. Toro, E. Stefani, M. J. Watt, S. Schenk, T. Akerstrom, M. Kelly, B. K. Pedersen, S. C. Hewitt, K. S. Korach, A. L. Hevener, Skeletal muscle action of estrogen receptor a is critical for the maintenance of mitochondrial function and metabolic homeostasis in females. Sci. Transl. Med. 8, 334ra54 (2016).
139. B. G. Drew, V. Ribas, J. A. Le, D. C. Henstridge, J. Phun, Z. Zhou, T. Soleymani, P. Daraei, D. Sitz, L. Vergnes, J. Wanagat, K. Reue, M. A. Febbraio, A. L. Hevener, Hsp72 is a mitochondrial stress sensor critical for Parkin action, oxidative metabolism, and insulin sensitivity in skeletal muscle. Diabetes 63, 1488-1505 (2014).
140. K.-Y. Kim, M. V. Stevens, M. H. Akter, S. E. Rusk, R. J. Huang, A. Cohen, A. Noguchi, D. Springer, A. V. Bocharov, T. L. Eggerman, D.-F. Suen, R. J. Youle, M. Amar, A. T. Remaley, M. N. Sack, Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J. Clin. Invest. 121, 3701-3712 (2011).
141. A. Hoshino, M. Ariyoshi, Y. Okawa, S. Kaimoto, M. Uchihashi, K. Fukai, E. Iwai-Kanai, K. Ikeda, T. Ueyama, T. Ogata, S. Matoba, Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic b-cell function in diabetes. Proc. Natl. Acad. Sci. U.S.A. 111, 3116-3121 (2014).
142. S. M. Shenouda, M. E. Widlansky, K. Chen, G. Xu, M. Holbrook, C. E. Tabit, N. M. Hamburg, A. A. Frame, T. L. Caiano, M. A. Kluge, M.-A. Duess, A. Levit, B. Kim, M.-L. Hartman, L. Joseph, O. S. Shirihai, J. A. Vita, Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124, 444-453 (2011).
143. C. E. Tabit, S. M. Shenouda, M. Holbrook, J. L. Fetterman, S. Kiani, A. A. Frame, M. A. Kluge, A. Held, M. M. Dohadwala, N. Gokce, M. G. Farb, J. Rosenzweig, N. Ruderman, J. A. Vita, N. M. Hamburg, Protein kinase C-b contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation 127, 86-95 (2013).
144. J. L. Fetterman, M. Holbrook, N. Flint, B. Feng, R. Bretn-Romero, E. A. Linder, B. D. Berk, M.-A. Duess, M. G. Farb, N. Gokce, O. S. Shirihai, N. M. Hamburg, J. A. Vita, Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling. Atherosclerosis 247, 207-217 (2016).
145. T. J. LaRocca, G. D. Henson, A. Thorburn, A. L. Sindler, G. L. Pierce, D. R. Seals, Translational evidence that impaired autophagy contributes to arterial ageing. J. Physiol. 590, 3305-3316 (2012).
146. T. Wai, J. García-Prieto, M. J. Baker, C. Merkwirth, P. Benit, P. Rustin, F. J. Rupérez, C. Barbas, B. Ibañez, T. Langer, Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science 350, aad0116 (2015).
147. M. Song, Y. Chen, G. Gong, E. Murphy, P. S. Rabinovitch, G. W. Dorn, Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy. Circ. Res. 115, 348-353 (2014).
148. F. Billia, L. Hauck, F. Konecny, V. Rao, J. Shen, T. W. Mak, PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc. Natl. Acad. Sci. U.S.A. 108, 9572-9577 (2011).
149. D. Montaigne, X. Marechal, A. Coisne, N. Debry, T. Modine, G. Fayad, C. Potelle, J.-M. El Arid, S. Mouton, Y. Sebti, H. Duez, S. Preau, I. Remy-Jouet, F. Zerimech, M. Koussa, V. Richard, R. Neviere, J.-L. Edme, P. Lefebvre, B. Staels, Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation 130, 554-564 (2014).
150. R. Singh, Y. Xiang, Y. Wang, K. Baikati, A. M. Cuervo, Y. K. Luu, Y. Tang, J. E. Pessin, G. J. Schwartz, M. J. Czaja, Autophagy regulates adipose mass and differentiation in mice. J. Clin. Invest. 119, 3329-3339 (2009).
151. E. Jeffery, R. Berry, C. D. Church, S. Yu, B. A. Shook, V. Horsley, E. D. Rosen, M. S. Rodeheffer, Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte 3, 206-211 (2014).
152. K. Martens, A. Bottelbergs, M. Baes, Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: Implications for metabolism research. FEBS Lett. 584, 1054-1058 (2010).
153. S. Altshuler-Keylin, K. Shinoda, Y. Hasegawa, K. Ikeda, H. Hong, Q. Kang, Y. Yang, R. M. Perera, J. Debnath, S. Kajimura, Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance. Cell Metab. 24, 402-419 (2016).
154. M. J. Tol, R. Ottenhoff, M. van Eijk, N. Zelcer, J. Aten, S. M. Houten, D. Geerts, C. van Roomen, M. C. Bierlaagh, S. Scheij, M. A. Hoeksema, J. M. Aerts, J. S. Bogan, G. W. Dorn 2nd, C. A. Argmann, A. J. Verhoeven, A PPARg-Bnip3 axis couples adipose mitochondrial fusion-fission balance to systemic insulin sensitivity. Diabetes 65. 2591-2605 (2016).
155. S. Virtue, A. Vidal-Puig, Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-An allostatic perspective. Biochim. Biophys. Acta 1801, 338-349 (2010).
156. N. A. van Herpen, V. B. Schrauwen-Hinderling, Lipid accumulation in non-Adipose tissue and lipotoxicity. Physiol. Behav. 94, 231-241 (2008).
157. M. Ouimet, Y. L. Marcel, Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 32, 575-581 (2012).
158. R. Singh, S. Kaushik, Y. Wang, Y. Xiang, I. Novak, M. Komatsu, K. Tanaka, A. M. Cuervo, M. J. Czaja, Autophagy regulates lipid metabolism. Nature 458, 1131-1135 (2009).
159. D. Lettieri Barbato, G. Tatulli, K. Aquilano, M. R. Ciriolo, FoxO1 controls lysosomal acid lipase in adipocytes: Implication of lipophagy during nutrient restriction and metformin treatment. Cell Death Dis. 4, e861 (2013).
160. S. W. Eastman, M. Yassaee, P. D. Bieniasz, A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. J. Cell Biol. 184, 881-894 (2009).
161. Z. Nian, Z. Sun, L. Yu, S. Y. Toh, J. Sang, P. Li, Fat-specific protein 27 undergoes ubiquitindependent degradation regulated by triacylglycerol synthesis and lipid droplet formation. J. Biol. Chem. 285, 9604-9615 (2010).
162. T. Fujimoto, Y. Ohsaki, Proteasomal and autophagic pathways converge on lipid droplets. Autophagy 2, 299-301 (2006).
163. J. Kovsan, R. Ben-Romano, S. C. Souza, A. S. Greenberg, A. Rudich, Regulation of adipocyte lipolysis by degradation of the perilipin protein: Nelfinavir enhances lysosomemediated perilipin proteolysis. J. Biol. Chem. 282, 21704-21711 (2007).
164. B. Schroeder, R. J. Schulze, S. G. Weller, A. C. Sletten, C. A. Casey, M. A. McNiven, The small GTPase Rab7 as a central regulator of hepatocellular lipophagy. Hepatology 61, 1896-1907 (2015).
165. N. Martinez-Lopez, M. Garcia-Macia, S. Sahu, D. Athonvarangkul, E. Liebling, P. Merlo, F. Cecconi, G. J. Schwartz, R. Singh, Autophagy in the CNS and periphery coordinate lipophagy and lipolysis in the brown adipose tissue and liver. Cell Metab. 23, 113-127 (2016).
166. J. Geng, D. J. Klionsky, The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. "Protein modifications: Beyond the usual suspects" review series. EMBO Rep. 9, 859-864 (2008).
167. A. S. Rambold, S. Cohen, J. Lippincott-Schwartz, Fatty acid trafficking in starved cells: Regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev. Cell 32, 678-692 (2015).
168. M. Shibata, K. Yoshimura, N. Furuya, M. Koike, T. Ueno, M. Komatsu, H. Arai, K. Tanaka, E. Kominami, Y. Uchiyama, The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem. Biophys. Res. Commun. 382, 419-423 (2009).
169. J. Dengjel, A. R. Kristensen, J. S. Andersen, Ordered bulk degradation via autophagy. Autophagy 4, 1057-1059 (2008).
170. S. Kaushik, A. M. Cuervo, Degradation of lipid droplet-Associated proteins by chaperonemediated autophagy facilitates lipolysis. Nat. Cell Biol. 17, 759-770 (2015).
171. R. T. Brookheart, C. I. Michel, J. E. Schaffer, As a matter of fat. Cell Metab. 10, 9-12 (2009).
172. L. Yang, P. Li, S. Fu, E. S. Calay, G. S. Hotamisligil, Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11, 467-478 (2010).
173. J. Kashima, K. Shintani-Ishida, M. Nakajima, H. Maeda, K. Unuma, Y. Uchiyama, K.-i. Yoshida, Immunohistochemical study of the autophagy marker microtubuleassociated protein 1 light chain 3 in normal and steatotic human livers. Hepatol. Res. 44, 779-787 (2014).
174. M. Ouimet, V. Franklin, E. Mak, X. Liao, I. Tabas, Y. L. Marcel, Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab. 13, 655-667 (2011).
175. I. Sergin, T. D. Evans, B. Razani, Degradation and beyond: The macrophage lysosome as a nexus for nutrient sensing and processing in atherosclerosis. Curr. Opin. Lipidol. 26, 394-404 (2015).
176. T. Hendrikx, S. M. A. Walenbergh, M. H. Hofker, R. Shiri-Sverdlov, Lysosomal cholesterol accumulation: Driver on the road to inflammation during atherosclerosis and nonalcoholic steatohepatitis. Obes. Rev. 15, 424-433 (2014).
177. A. E. Feldstein, N. W. Werneburg, A. Canbay, M. E. Guicciardi, S. F. Bronk, R. Rydzewski, L. J. Burgart, G. J. Gores, Free fatty acids promote hepatic lipotoxicity by stimulating TNF-A expression via a lysosomal pathway. Hepatology 40, 185-194 (2004).
178. H. Du, M. Heur, M. Duanmu, G. A. Grabowski, D. Y. Hui, D. P. Witte, J. Mishra, Lysosomal acid lipase-deficient mice: Depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span. J. Lipid Res. 42, 489-500 (2001).
179. P. M. Coates, T. Langer, J. A. Cortner, Genetic variation of human mononuclear leukocyte lysosomal acid lipase activity. Relationship to atherosclerosis. Atherosclerosis 62, 11-20 (1986).
180. T. Reynolds, Cholesteryl ester storage disease: A rare and possibly treatable cause of premature vascular disease and cirrhosis. J. Clin. Pathol. 66, 918-923 (2013).
181. X. Xu, A. Grijalva, A. Skowronski, M. van Eijk, M. J. Serlie, A. W. Ferrante Jr., Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 18, 816-830 (2013).
182. A. Grijalva, X. Xu, A. W. Ferrante Jr., Autophagy is dispensable for macrophage-mediated lipid homeostasis in adipose tissue. Diabetes 65, 967-980 (2016).
183. Y. Nishida, S. Arakawa, K. Fujitani, H. Yamaguchi, T. Mizuta, T. Kanaseki, M. Komatsu, K. Otsu, Y. Tsujimoto, S. Shimizu, Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461, 654-658 (2009).
184. A. S. Haka, V. C. Barbosa-Lorenzi, H. J. Lee, D. J. Falcone, C. A. Hudis, A. J. Dannenberg, F. R. Maxfield, Exocytosis of macrophage lysosomes leads to digestion of apoptotic adipocytes and foam cell formation. J. Lipid Res. 57, 980-992 (2016).
185. C. Settembre, C. Di Malta, V. A. Polito, M. Garcia Arencibia, F. Vetrini, S. Erdin, S. U. Erdin, T. Huynh, D. Medina, P. Colella, M. Sardiello, D. C. Rubinsztein, A. Ballabio, TFEB links autophagy to lysosomal biogenesis. Science 332, 1429-1433 (2011).
186. M. Sardiello, M. Palmieri, A. di Ronza, D. L. Medina, M. Valenza, V. A. Gennarino, C. Di Malta, F. Donaudy, V. Embrione, R. S. Polishchuk, S. Banfi, G. Parenti, E. Cattaneo, A. Ballabio, A gene network regulating lysosomal biogenesis and function. Science 325, 473-477 (2009).
187. J. A. Martina, H. I. Diab, L. Lishu, L. Jeong-A, S. Patange, N. Raben, R. Puertollano, The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci. Signal. 7, ra9 (2014).
188. C. Catania, E. Binder, D. Cota, mTORC1 signaling in energy balance and metabolic disease. Int. J. Obes. 35, 751-761 (2011).
189. A. Roczniak-Ferguson, C. S. Petit, F. Froehlich, S. Qian, J. Ky, B. Angarola, T. C. Walther, S. M. Ferguson, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5, ra42 (2012).
190. J. A. Martina, Y. Chen, M. Gucek, R. Puertollano, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903-914 (2012).
191. C. Settembre, R. Zoncu, D. L. Medina, F. Vetrini, S. Erdin, S. Erdin, T. Huynh, M. Ferron, G. Karsenty, M. C. Vellard, V. Facchinetti, D. M. Sabatini, A. Ballabio, A lysosome-Tonucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31, 1095-1108 (2012).
192. C. L. Nezich, C. Wang, A. I. Fogel, R. J. Youle, MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J. Cell Biol. 210, 435-450 (2015).
193. D. Ivankovic, K.-Y. Chau, A. H. V. Schapira, M. E. Gegg, Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin-mediated mitophagy. J. Neurochem. 136, 388-402 (2016).
194. C. Settembre, R. De Cegli, G. Mansueto, P. K. Saha, F. Vetrini, O. Visvikis, T. Huynh, A. Carissimo, D. Palmer, T. J. Klisch, A. C. Wollenberg, D. Di Bernardo, L. Chan, J. E. Irazoqui, A. Ballabio, TFEB controls cellular lipid metabolism through a starvationinduced autoregulatory loop. Nat. Cell Biol. 15, 647-658 (2013).
195. P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, B. M. Spiegelman, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
196. M. Pajares, N. Jiménez-Moreno, Á. J. García-Yagüe, M. Escoll, M. L. de Ceballos, F. Van Leuven, A. Rábano, M. Yamamoto, A. I. Rojo, A. Cuadrado, Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy 12, 1902-1916 (2016).
197. A. Jain, T. Lamark, E. Sjøttem, K. B. Larsen, J. A. Awuh, A. Øvervatn, M. McMahon, J. D. Hayes, T. Johansen, p62/SQSTM1 is a target gene for transcription factor Nrf2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285, 22576-22591 (2010).
198. J. Kwon, E. Han, C.-B. Bui, W. Shin, J. Lee, S. Lee, Y.-B. Choi, A.-H. Lee, K.-H. Lee, C. Park, M. S. Obin, S. K. Park, Y. J. Seo, G. T. Oh, H.-W. Lee, J. Shin, Assurance of mitochondrial integrity and mammalian longevity by the p62-Keap1-Nrf2-Nqo1 cascade. EMBO Rep. 13, 150-156 (2012).
199. A. Kobayashi, M.-I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, M. Yamamoto, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139 (2004).
200. Y. Ichimura, E. Kominami, K. Tanaka, M. Komatsu, Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy 4, 1063-1066 (2008).
201. A. Lau, X.-J. Wang, F. Zhao, N. F. Villeneuve, T. Wu, T. Jiang, Z. Sun, E. White, D. D. Zhang, A noncanonical mechanism of Nrf2 activation by autophagy deficiency: Direct interaction between Keap1 and p62. Mol. Cell. Biol. 30, 3275-3285 (2010).
202. R. K. Vadlamudi, J. Shin, Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein. FEBS Lett. 435, 138-142 (1998).
203. L. Sanz, M. T. Diaz-Meco, H. Nakano, J. Moscat, The atypical PKC-interacting protein p62 channels NF-kB activation by the IL-1-TRAF6 pathway. EMBO J. 19, 1576-1586 (2000).
204. A. Duran, R. Amanchy, J. F. Linares, J. Joshi, S. Abu-Baker, A. Porollo, M. Hansen, J. Moscat, M. T. Diaz-Meco, P62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol. Cell 44, 134-146 (2011).
205. J. F. Linares, A. Duran, T. Yajima, M. Pasparakis, J. Moscat, M. T. Diaz-Meco, K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrientactivated cells. Mol. Cell 51, 283-296 (2013).
206. G.-Y. Kim, P. Nigro, K. Fujiwara, J.-i. Abe, B. C. Berk, p62 binding to protein kinase C z regulates tumor necrosis factor a-induced apoptotic pathway in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 32, 2974-2980 (2012).
207. S. J. Lee, P. T. Pfluger, J. Y. Kim, R. Nogueiras, A. Duran, G. Pagès, J. Pouysségur, M. H. Tschöp, M. T. Diaz-Meco, J. Moscat, A functional role for the p62-ERK1 axis in the control of energy homeostasis and adipogenesis. EMBO Rep. 11, 226-232 (2010).
208. A. Rodriguez, A. Durán, M. Selloum, M.-F. Champy, F. J. Diez-Guerra, J. M. Flores, M. Serrano, J. Auwerx, M. T. Diaz-Meco, J. Moscat, Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab. 3, 211-222 (2006).
209. H. Harada, E. Warabi, T. Matsuki, T. Yanagawa, K. Okada, J. Uwayama, A. Ikeda, K. Nakaso, K. Kirii, N. Noguchi, H. Bukawa, R. C. M. Siow, G. E. Mann, J. Shoda, T. Ishii, T. Sakurai, Deficiency of p62/Sequestosome 1 causes hyperphagia due to leptin resistance in the brain. J. Neurosci. 33, 14767-14777 (2013).
210. Y. Mei, Y. Zhang, K. Yamamoto, W. Xie, T. W. Mak, H. You, FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. DNA Seq. 106, 5153-5158 (2009).
211. C. Mammucari, G. Milan, V. Romanello, E. Masiero, R. Rudolf, P. Del Piccolo, S. J. Burden, R. Di Lisi, C. Sandri, J. Zhao, A. L. Goldberg, S. Schiaffino, M. Sandri, FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6, 458-471 (2007).
212. D. J. Cao, N. Jiang, A. Blagg, J. L. Johnstone, R. Gondalia, M. Oh, X. Luo, K.-C. Yang, J. M. Shelton, B. A. Rothermel, T. G. Gillette, G. W. Dorn, J. A. Hill, Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy. J. Am. Heart Assoc. 2, e000016 (2013).
213. A. E. Webb, A. Brunet, FOXO transcription factors: Key regulators of cellular quality control. Trends Biochem. Sci. 39, 159-169 (2014).
214. J.-O. Pyo, S.-M. Yoo, H.-H. Ahn, J. Nah, S.-H. Hong, T.-I. Kam, S. Jung, Y.-K. Jung, Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat. Commun. 4, 2300 (2013).
215. H. Koga, S. Kaushik, A. M. Cuervo, Altered lipid content inhibits autophagic vesicular fusion. FASEB J. 24, 3052-3065 (2010).
216. A. Eiyama, N. Kondo-Okamoto, K. Okamoto, Mitochondrial degradation during starvation is selective and temporally distinct from bulk autophagy in yeast. FEBS Lett. 587, 1787-1792 (2013).
217. T. Fukuda, L. Ewan, M. Bauer, R. J. Mattaliano, K. Zaal, E. Ralston, P. H. Plotz, N. Raben, Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann. Neurol. 59, 700-708 (2006).
218. C. Settembre, A. Fraldi, L. Jahreiss, C. Spampanato, C. Venturi, D. Medina, R. de Pablo, C. Tacchetti, D. C. Rubinsztein, A. Ballabio, A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 17, 119-129 (2008).
219. B. T. Tam, P. M. Siu, Autophagic cellular responses to physical exercise in skeletal muscle. Sports Med. 44, 625-640 (2014).
220. F. Madeo, A. Zimmermann, M. C. Maiuri, G. Kroemer, Essential role for autophagy in life span extension. J. Clin. Invest. 125, 85-93 (2015).
221. A. Ulbricht, S. Gehlert, B. Leciejewski, T. Schiffer, W. Bloch, J. Höhfeld, Induction and adaptation of chaperone-Assisted selective autophagy CASA in response to resistance exercise in human skeletal muscle. Autophagy 11, 538-546 (2015).
222. C. He, M. C. Bassik, V. Moresi, K. Sun, Y. Wei, Z. Zou, Z. An, J. Loh, J. Fisher, Q. Sun, S. Korsmeyer, M. Packer, H. I. May, J. A. Hill, H. W. Virgin, C. Gilpin, G. Xiao, R. Bassel-Duby, P. E. Scherer, B. Levine, Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481, 511-515 (2012).
223. K. E. Kim, Y. Jung, S. Min, M. Nam, R. W. Heo, B. T. Jeon, D. H. Song, C.-o. Yi, E. A. Jeong, H. Kim, J. Kim, S.-Y. Jeong, W. Kwak, D. H. Ryu, T. L. Horvath, G. S. Roh, G.-S. Hwang, Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism. Sci. Rep. 6, 30111 (2016).
224. R. J. Godar, X. Ma, H. Liu, J. T. Murphy, C. J. Weinheimer, A. Kovacs, S. D. Crosby, P. Saftig, A. Diwan, Repetitive stimulation of autophagy-lysosome machinery by intermittent fasting preconditions the myocardium to ischemia-reperfusion injury. Autophagy 11, 1537-1560 (2015).
225. Y. Nakagawa, H. Shimano, T. Yoshikawa, T. Ide, M. Tamura, M. Furusawa, T. Yamamoto, N. Inoue, T. Matsuzaka, A. Takahashi, A. H. Hasty, H. Suzuki, H. Sone, H. Toyoshima, N. Yahagi, N. Yamada, TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat. Med. 12, 107-113 (2006).
226. H. Iwasaki, A. Naka, K. T. Iida, Y. Nakagawa, T. Matsuzaka, K.-A. Ishii, K. Kobayashi, A. Takahashi, S. Yatoh, N. Yahagi, H. Sone, H. Suzuki, N. Yamada, H. Shimano, TFE3 regulates muscle metabolic gene expression, increases glycogen stores, and enhances insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 302, E896-E902 (2012).
227. A. R. Johnson, J. J. Milner, L. Makowski, The inflammation highway: Metabolism accelerates inflammatory traffic in obesity. Immunol. Rev. 249, 218-238 (2012).
228. G. S. Shadel, T. L. Horvath, Mitochondrial ROS signaling in organismal homeostasis. Cell 163, 560-569 (2015).
229. J. Kim, M. Kundu, B. Viollet, K.-L. Guan, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141 (2011).
230. D. F. Egan, D. B. Shackelford, M. M. Mihaylova, S. Gelino, R. A. Kohnz, W. Mair, D. S. Vasquez, A. Joshi, D. M. Gwinn, R. Taylor, J. M. Asara, J. Fitzpatrick, A. Dillin, B. Viollet, M. Kundu, M. Hansen, R. J. Shaw, Phosphorylation of ULK1 (hATG1) by AMPactivated protein kinase connects energy sensing to mitophagy. Science 331, 456-461 (2011).
231. Z. Z. Chong, K. Maiese, Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc. Diabetol. 11, 45 (2012).
232. B. J. DeBosch, M. R. Heitmeier, A. L. Mayer, C. B. Higgins, J. R. Crowley, T. E. Kraft, M. Chi, E. P. Newberry, Z. Chen, B. N. Finck, N. O. Davidson, K. E. Yarasheski, P. W. Hruz, K. H. Moley, Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis. Sci. Signal. 9, ra21 (2016).
233. R. E. Kaplon, S. D. Hill, N. Z. Bispham, J. R. Santos-Parker, M. J. Nowlan, L. L. Snyder, M. Chonchol, T. J. LaRocca, M. B. McQueen, D. R. Seals, Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-Aged and older adults. Aging 8, 1167-1183 (2016).
234. C. Arai, N. Arai, A. Mizote, K. Kohno, K. Iwaki, T. Hanaya, S. Arai, S. Ushio, S. Fukuda, Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance. Nutr. Res. 30, 840-848 (2010).
235. A. B. Richards, S. Krakowka, L. B. Dexter, H. Schmid, A. P. M. Wolterbeek, D. H. Waalkens-Berendsen, A. Shigoyuki, M. Kurimoto, Trehalose: A review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem. Toxicol. 40, 871-898 (2002).
236. S.-i. Wada, R. Sawa, S.-i. Ohba, C. Hayashi, M. Umekita, Y. Shibuya, K. Iijima, F. Iwanami, M. Igarashi, Stability and bioavailability of lentztrehaloses A, B, and C as replacements for trehalose. J. Agric. Food Chem. 64, 7121-7126 (2016).
237. E. Morselli, G. Mariño, M. V. Bennetzen, T. Eisenberg, E. Megalou, S. Schroeder, S. Cabrera, P. Bénit, P. Rustin, A. Criollo, O. Kepp, L. Galluzzi, S. Shen, S. A. Malik, M. C. Maiuri, Y. Horio, C. López-Otín, J. S. Andersen, N. Tavernarakis, F. Madeo, G. Kroemer, Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J. Cell Biol. 192, 615-629 (2011).
238. T. J. LaRocca, R. A. Gioscia-Ryan, C. M. Hearon Jr., D. R. Seals, The autophagy enhancer spermidine reverses arterial aging. Mech. Ageing Dev. 134, 314-320 (2013).
239. C. F. Michiels, A. Kurdi, J.-P. Timmermans, G. R. Y. De Meyer, W. Martinet, Spermidine reduces lipid accumulation and necrotic core formation in atherosclerotic plaques via induction of autophagy. Atherosclerosis 251, 319-327 (2016).
240. D. C. Rubinsztein, P. Codogno, B. Levine, Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11, 709-730 (2012).
241. M. I. Nilsson, L. G. MacNeil, Y. Kitaoka, R. Suri, S. P. Young, J. J. Kaczor, N. J. Nates, M. U. Ansari, T. Wong, M. Ahktar, L. Brandt, B. P. Hettinga, M. A. Tarnopolsky, Combined aerobic exercise and enzyme replacement therapy rejuvenates the mitochondrial- lysosomal axis and alleviates autophagic blockage in Pompe disease. Free Radic. Biol. Med. 87, 98-112 (2015).
242. D. L. Medina, S. Di Paola, I. Peluso, A. Armani, D. De Stefani, R. Venditti, S. Montefusco, A. Scotto-Rosato, C. Prezioso, A. Forrester, C. Settembre, W. Wang, Q. Gao, H. Xu, M. Sandri, R. Rizzuto, M. A. De Matteis, A. Ballabio, Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17, 288-299 (2015).
243. V. A. Lira, M. Okutsu, M. Zhang, N. P. Greene, R. C. Laker, D. S. Breen, K. L. Hoehn, Z. Yan, Autophagy is required for exercise training-induced skeletal muscle adaptation and improvement of physical performance. FASEB J. 27, 4184-4193 (2013).
244. K. C. Jackson, E.-K. Gidlund, J. Norrbom, A. P. Valencia, D. M. Thomson, R. A. Schuh, P. D. Neufer, E. E. Spangenburg, BRCA1 is a novel regulator of metabolic function in skeletal muscle. J. Lipid Res. 55, 668-680 (2014).
245. S. Kume, T. Uzu, K. Horiike, M. Chin-Kanasaki, K. Isshiki, S.-i. Araki, T. Sugimoto, M. Haneda, A. Kashiwagi, D. Koya, Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 120, 1043-1055 (2010).
246. L. R. Lapierre, C. D. De Magalhaes Filho, P. R. McQuary, C.-C. Chu, O. Visvikis, J. T. Chang, S. Gelino, B. Ong, A. E. Davis, J. E. Irazoqui, A. Dillin, M. Hansen, The TFEB orthologue HLH-30 regulates autophagy and modulates longevity in Caenorhabditis elegans. Nat. Commun. 4, 2267 (2013).
247. M. H. Sahani, E. Itakura, N. Mizushima, Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy 10, 431-441 (2014).
248. J. Xiong, K. Wang, J. He, G. Zhang, D. Zhang, F. Chen, TFE3 alleviates hepatic steatosis through autophagy-induced lipophagy and PGC1a-mediated fatty acid b-oxidation. Int. J. Mol. Sci. 17, 387 (2016).
249. X. Zhang, S. Chen, L. Song, Y. Tang, Y. Shen, L. Jia, W. Le, MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy 10, 588-602 (2014).
250. K. Castillo, M. Nassif, V. Valenzuela, F. Rojas, S. Matus, G. Mercado, F. A. Court, B. van Zundert, Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9, 1308-1320 (2013).
251. S. Sarkar, J. E. Davies, Z. Huang, A. Tunnacliffe, D. C. Rubinsztein, Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and a-synuclein. J. Biol. Chem. 282, 5641-5652 (2007).
252. Y. Qi, Q. Qiu, X. Gu, Y. Tian, Y. Zhang, ATM mediates spermidine-induced mitophagy via PINK1 and Parkin regulation in human fibroblasts. Sci. Rep. 6, 24700 (2016).